Literature DB >> 15124537

Fundus analysis and visual prognosis of macular hemorrhage in pathological myopia without choroidal neovasculopathy.

Haitao Li1, Feng Wen, De-zheng Wu, Guangwei Luo, Shizhou Huang, Tianqin Guan, Caijiao Liu.   

Abstract

PURPOSE: To analysis and evaluate the fundus characteristics and visual prognosis of macular hemorrhage in pathological myopia without choroidal neovasculopathy.
METHODS: Thirty-seven patients (38 eyes) of pathological myopia with macular hemorrhage and without choroidal neovascularization (CNV) underwent color photograph and fundus fluorescein angiography (FFA) examinations. Indocyanine green angiography (ICGA) was also performed on 11 patients (11 eyes). Follow-up ranged from 3 to 21 months.
RESULTS: The macular hemorrhage in pathological myopia without CNV demonstrated oval, less than 1PD, without edema and exudation. Lacquer cracks appeared at the site of previous subretinal bleeding in 84.2% of the eyes. The visual acuities were improved in 81.6% of eyes during the follow-up period. ICGA revealed linear hypofluorescence in 7 of 11 eyes (63.6%), indicating a ruptured Bruch's membrance at the onset of subretinal bleeding.
CONCLUSION: A rupture of choriocapillaris complex and Bruch's membrane causes macular hemorrhage of pathological myopia without CNV, leading to the formation of a new lacquer crack. Its prognosis is favorable.

Entities:  

Mesh:

Year:  2004        PMID: 15124537

Source DB:  PubMed          Journal:  Yan Ke Xue Bao        ISSN: 1000-4432


  2 in total

1.  Multimodal imaging of linear lesions in the fundus of pathologic myopic eyes with macular lesions.

Authors:  Kuo-Chi Hung; Muh-Shy Chen; Chung-May Yang; Shih-Wen Wang; Tzyy-Chang Ho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-31       Impact factor: 3.117

2.  Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization.

Authors:  Kuei-Jung Chang; Cheng-Kuo Cheng; Chi-Hsien Peng
Journal:  Taiwan J Ophthalmol       Date:  2016-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.